About 3DHEALS Company Directory:

3DHEALS updates this collection of public and private companies, government and non-government institutions, and any relevant research organizations in healthcare 3D printing, bioprinting, AR/VR, 3D technologies, on a weekly basis. Access to this directory is free to 3DHEALS Premium and Enterprise members. 

THIS CONTENT IS FOR PREMIUM AND ENTERPRISE MEMBERS ONLY.

Register

Add your company to 3DHEALS Directory:

(Please click the same above buttons for significant updates of your organizational information. Map is updated monthly.)

blank

ChemoSen3D

Nano3D Biosciences (n3D) is a biotechnology startup located in Houston, TX focused on 3D cell culture solutions for biomedical research, drug discovery, toxicology, precision medicine, and regenerative medicine.

Headquarters 7000 Fannin Street Suite 2140 Houston TX 77030 United States
  • blank
  • blank
  • blank
Categories: Bioprinting /Biofabrication
Website: chemosen3d.com/
Youtube: www.youtube.com/
LinkedIn: www.linkedin.com/company/chemosen3d
Facebook: www.facebook.com/Nano3D-Biosciences-Inc-n3D-97488193220/
Twitter: twitter.com/ChemoSen3D
Phone: +1(713)790-1833
Links:

Details

ChemoSen3D was known as n3D Biosciences previously

Chemosen3D proprietary magnetic 3D-based platform tests anti-cancer agents ex vivo  to determine reactive therapies on a per patient basis, avoiding the cost and risk to individuals of receiving ineffective drug regimens. ChemoSen3D’s functional 3D assay is poised to be part of pre-screening protocols, along with molecular testing, for personalized treatment decisions. Our approach utilizes magnetic 3D bio-printing to create patient-derived spheroid for chemo-response testing which maintains tissue heterogeneity: a critical factor for drugresponse determination in physiologically relevant models that will accelerate precision medicine profiling of cancer.

ChemoSen3D grew out of Nano3D Biosciences (n3D) which was a State of Texas C-Corporation founded in 2008 by Glauco R. Souza, Thomas Killian, David Lee, and Robert Raphael. n3D commercialized products and services utilizing the Bio-Assembler™ technology created by Glauco R. Souza (U.T. MD Anderson Cancer Center), Thomas Killian (Rice University) and Robert Raphael (Rice University). The n3D business strategy has been created by all team members under the business leadership of David Lee. n3D was a Houston Technology Center client company, and it had been recognized with a Rice Alliance “Most Promising Life Science Company” award (2009), received approximately $2,000,000 in non-diluting funds from grants, a Pre-Seed Commercialization Award of $1,000,000 from the Texas Emerging Technology Fund (2010), and a $10,000 Goradia Innovation Prize (2010). N3D’s magnetic 3D culturing technology was sold to Greiner-Bio One in 2018 and now ChemoSen3D is moving forward into the clinical diagnostic space.

CBD for pain is gaining traction as a complementary option for everyday discomfort, offering potential anti-inflammatory benefits and calmer sensations without strong sedatives. Results vary, so start with a low dose, choose reputable full- or broad-spectrum products, and monitor changes. Always consult a healthcare professional if you have underlying conditions or take other medications. cbdclub.top